{
    "nct_id": "NCT06489041",
    "official_title": "Evaluating the Use of Microarray Pharmacogenetic Testing in Patients With Cancer",
    "inclusion_criteria": "* Written informed consent and HIPAA authorization for release of personal health information.\n* Age ≥ 18 years at the time of consent.\n* Eligible for standard of care single-gene DPYD testing (i.e., receiving or expected to receive a fluoropyrimidine-based chemotherapy regimen). The potential participant meets inclusion criteria if the standard of care single-gene DPYD test is planned or previously ordered. If previously ordered, consent must occur no later than 60 days from the date the DPYD results were available.\n* Willing to provide additional buccal swabs if residual DNA from previous DPYD testing is inadequate for microarray testing.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "• History of prior allogeneic hematopoietic cell transplantation or liver transplantation",
    "miscellaneous_criteria": ""
}